Ken Griffin Zai Lab LTD Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Zai Lab LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 8,000 shares of ZLAB stock, worth $251,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,000

Previous 18,200 56.04%

Holding current value

$251,440

Previous $291,000 52.58%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$13.72 - $21.55 $3.28 Million - $5.15 Million	239,092 Added 36.19%	899,666 $15.6 Million
Q1 2024 May 15, 2024	BUY	$15.95 - $26.8 $10 Million - $16.9 Million	629,984 Added 2059.44%	660,574 $10.6 Million
Q4 2023 Feb 14, 2024	SELL	$22.97 - $30.58 $2.52 Million - $3.35 Million	-109,615 Reduced 78.18%	30,590 $836,000
Q3 2023 Nov 14, 2023	SELL	$22.72 - $31.49 $1.43 Million - $1.99 Million	-63,126 Reduced 31.05%	140,205 $3.41 Million
Q2 2023 Aug 14, 2023	BUY	$25.3 - $39.67 $3.93 Million - $6.16 Million	155,313 Added 323.45%	203,331 $5.64 Million
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $834,823 - $1.33 Million	27,634 Added 135.57%	48,018 $1.6 Million
Q4 2022 Feb 14, 2023	BUY	$22.28 - $38.71 $454,155 - $789,064	20,384 New	20,384 $625,000
Q2 2022 Aug 15, 2022	BUY	$23.14 - $49.68 $684,110 - $1.47 Million	29,564 Added 59.75%	79,043 $2.74 Million
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $5.04 Million - $9.66 Million	-91,853 Reduced 64.99%	49,479 $3.11 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $12.3 Million - $20.9 Million	117,099 Added 483.22%	141,332 $14.9 Million
Q2 2021 Aug 16, 2021	SELL	$125.11 - $180.0 $1.28 Million - $1.84 Million	-10,198 Reduced 29.62%	24,233 $4.29 Million
Q1 2021 May 17, 2021	BUY	$126.27 - $191.71 $4.09 Million - $6.2 Million	32,366 Added 1567.36%	34,431 $4.59 Million
Q4 2020 Feb 16, 2021	SELL	$81.94 - $135.34 $141,838 - $234,273	-1,731 Reduced 45.6%	2,065 $279,000
Q3 2020 Nov 16, 2020	SELL	$73.3 - $89.48 $872,343 - $1.06 Million	-11,901 Reduced 75.82%	3,796 $316,000
Q2 2020 Aug 14, 2020	SELL	$48.82 - $82.53 $2.37 Million - $4 Million	-48,471 Reduced 75.54%	15,697 $1.29 Million
Q4 2019 Feb 14, 2020	SELL	$29.79 - $43.06 $175,194 - $253,235	-5,881 Reduced 8.4%	64,168 $2.67 Million
Q3 2019 Nov 14, 2019	BUY	$30.47 - $37.65 $1.05 Million - $1.3 Million	34,572 Added 97.45%	70,049 $2.27 Million
Q2 2019 Aug 14, 2019	BUY	$25.73 - $35.79 $386,927 - $538,210	15,038 Added 73.58%	35,477 $1.24 Million
Q1 2019 May 15, 2019	BUY	$21.71 - $31.54 $73,054 - $106,132	3,365 Added 19.71%	20,439 $0
Q3 2018 Nov 13, 2018	BUY	$17.8 - $25.35 $303,917 - $432,825	17,074 New	17,074 $0

Others Institutions Holding ZLAB

# of Institutions

116

Shares Held

40.8M

Call Options Held

63.1K

Put Options Held

420K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.08B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account